Impella

Aachen, Germany Founded: 1998 • Age: 28 yrs Acquired By Abiomed
Ventricular assist devices are provided for cardiac hemodynamic support.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees 840 Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About Impella

Impella is a company based in Aachen (Germany) founded in 1998 was acquired by Abiomed in April 2005. The company has 840 employees as of December 31, 2022. Impella operates in a competitive market with competitors including Silk Road Medical, Lifetech Scientific Corporation, HDL Therapeutics, Supira Medical and Transvascular, among others.

  • Headquarter Aachen, Germany
  • Employees 840 as on 31 Dec, 2022
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Abiomed, Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    840

    as on Dec 31, 2022

  • Acquired by
    Abiomed

    (Apr 27, 2005)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Impella

Premium access

Detailed funding history for Impella

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in Impella

Impella has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Abiomed.

All
Institutional
Investor Description Founded Year Domain Location
Heart pumps are developed for blood circulation and oxygenation support.
Locked Locked Locked
Premium access

Investor details for Impella

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Impella

Investments
Premium access

Investment portfolio details for Impella

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Impella

Premium access

Detailed financials for Impella

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Impella Comparisons

Impella Primary company
Description
Ventricular assist devices are provided for cardiac hemodyna...
Location
Aachen, Germany
Founded Year
1998
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
840
As of 2022
Premium access

Peer comparison for Impella

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Impella

Impella operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Silk Road Medical, Lifetech Scientific Corporation, HDL Therapeutics, Supira Medical and Transvascular, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Provider of neuroprotection devices for carotid artery disease
Locked Locked Locked
Interventional devices for cardiovascular and vascular diseases are developed.
Locked Locked Locked
Therapy to reverse coronary atherosclerosis is developed using patient plasma.
Locked Locked Locked
Developer of ventricular assist devices for coronary intervention and cardiogenic shock
Locked Locked Locked
A TransAccess Catheter System that is used to deliver cells to damaged portions of the heart
Locked Locked Locked
Catheter ablation treatments for atrial fibrillation are developed.
Premium access

Detailed competitors of Impella

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Impella

Premium access

Complete news archive for Impella

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Impella

Impella was founded in 1998.

Impella is headquartered in Aachen, Germany. It is registered at Aachen, North Rhine-westphalia, Germany.

As of Dec 31, 2022, the latest employee count at Impella is 840.

Impella was founded in 1998 in Aachen, Germany, within the medical devices sector focused on cardiac care. Compact ventricular assist devices are developed and supplied to deliver hemodynamic support during procedures. These devices, smaller than a pencil in width, function as temporary heart pumps to maintain blood flow when native heart function is impaired, allowing recovery time. Operations emphasize innovation in minimally invasive cardiac solutions.

Impella has 1 investor. Key investors include Abiomed.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available